(
A) Same as
Figure 5C, but zoomed out to show the entire volcano plot. HeLa cells expressing nonfluorescent BFP (nfBFP) were infected with sgRNA against SAE1 (‘SAE1 knockdown’) or with nontargeting control (‘NT control’; same samples as
Figure 5C and
Figure 5—figure supplement 3C). Data were normalized to the mean of the mitochondrial proteome, rather than to that of the cellular proteome. The depletion of SAE1 is significant when data are normalized in this way. Upon knockdown of SAE1, seven tail-anchored proteins are significantly depleted while two are enriched (compared to 202 depleted and 197 enriched for the mitochondrial proteome overall). Note that FKBP8-1/2 are different isoforms of FKBP8 that were separately detected in the proteomic analysis. In western blot experiments, the largest isoform of the tail-anchored protein MAVS was depleted (
Figure 5A and B and
Figure 5—figure supplements 1 and
2, MW 57 kDa). The proteomics data does not distinguish between large isoform MAVS and its five smaller isoforms, four of which lack the C-terminal transmembrane domain. This may be why the proteomics data does not show a change in endogenous MAVS abundance when SAE1 is knocked down, whereas our western blot data in
Figure 5A and B does. (
B) Overexpression of SAE1 rescues the effects of SAE1 knockdown. HeLa cells expressing sgRNA-resistant SAE1 and sgRNA against endogenous SAE1 (‘SAE1 rescue’) were compared to the SAE1 knockdown cells from (
A). Proteins that were significantly depleted upon SAE1 knockdown vs. nontargeting control are generally enriched upon SAE1 vs. nfBFP overexpression, and vice versa. (
C) Representative traces of protein abundance in basal (left), SAE1 knockdown (middle), or SAE1 rescue (right) conditions. Data shown for three tail-anchored, three signal-anchored, one outer mitochondrial membrane, one inner mitochondrial membrane, and one intermembrane space protein. The three tail-anchored proteins track with the abundance of SAE1 itself.
†p<0.10, *p<0.05, **p<0.01, ***p<0.001, moderated t-test.